Last checked at 9 Feb 2021 13:30
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 08 February 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
2,300,244 | 1.78% | 619,596 | 0.48% | ||
(2) | Derivatives (other than options): | ||||
273,127 | 0.21% | 441,267 | 0.34% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 6,000 | 0.00% | 6,000 | 0.00% | |
| TOTAL: | |||||
2,579,371 | 2.00% | 1,066,863 | 0.83% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 224.1000 USD |
Purchase | 2 | 223.3400 USD |
Purchase | 3 | 222.6200 USD |
Purchase | 4 | 223.6325 USD |
Purchase | 5 | 223.8080 USD |
Purchase | 6 | 223.1900 USD |
Purchase | 27 | 224.1461 USD |
Purchase | 43 | 225.0430 USD |
Purchase | 100 | 224.9300 USD |
Purchase | 100 | 222.6450 USD |
Purchase | 100 | 221.9000 USD |
Purchase | 100 | 224.8500 USD |
Purchase | 202 | 222.9186 USD |
Purchase | 240 | 222.4775 USD |
Purchase | 300 | 223.9783 USD |
Purchase | 400 | 222.6887 USD |
Purchase | 414 | 223.1334 USD |
Purchase | 421 | 222.9499 USD |
Purchase | 438 | 222.8404 USD |
Purchase | 600 | 223.1658 USD |
Purchase | 620 | 223.8745 USD |
Purchase | 642 | 222.7244 USD |
Purchase | 657 | 224.7600 USD |
Purchase | 660 | 223.2040 USD |
Purchase | 700 | 223.6135 USD |
Purchase | 710 | 223.3690 USD |
Purchase | 719 | 223.8819 USD |
Purchase | 800 | 223.3562 USD |
Purchase | 830 | 223.2432 USD |
Purchase | 1,070 | 223.3983 USD |
Purchase | 1,375 | 223.1069 USD |
Purchase | 2,848 | 223.5638 USD |
Purchase | 5,084 | 224.6944 USD |
Purchase | 7,018 | 223.4405 USD |
Purchase | 7,573 | 223.9466 USD |
Purchase | 9,658 | 223.1370 USD |
Purchase | 9,794 | 225.6522 USD |
Purchase | 12,132 | 223.3190 USD |
Purchase | 13,000 | 221.6800 USD |
Purchase | 16,113 | 223.5231 USD |
Purchase | 19,537 | 225.7000 USD |
Purchase | 21,589 | 224.4113 USD |
Sale | 1 | 223.6800 USD |
Sale | 9 | 223.8833 USD |
Sale | 32 | 224.7784 USD |
Sale | 79 | 223.8617 USD |
Sale | 100 | 223.4800 USD |
Sale | 100 | 221.5900 USD |
Sale | 100 | 222.5550 USD |
Sale | 103 | 225.5700 USD |
Sale | 140 | 222.5742 USD |
Sale | 161 | 222.6847 USD |
Sale | 177 | 224.2800 USD |
Sale | 200 | 223.1900 USD |
Sale | 232 | 223.5281 USD |
Sale | 257 | 225.4599 USD |
Sale | 453 | 223.1941 USD |
Sale | 502 | 222.8300 USD |
Sale | 544 | 222.7107 USD |
Sale | 600 | 223.7900 USD |
Sale | 995 | 223.3439 USD |
Sale | 1,325 | 224.5822 USD |
Sale | 1,467 | 222.7963 USD |
Sale | 2,324 | 223.8101 USD |
Sale | 3,000 | 223.5521 USD |
Sale | 3,135 | 225.6844 USD |
Sale | 6,412 | 223.2540 USD |
Sale | 9,324 | 223.8009 USD |
Sale | 9,794 | 225.6522 USD |
Sale | 13,000 | 221.6800 USD |
Sale | 16,702 | 223.0732 USD |
Sale | 20,830 | 224.4428 USD |
Sale | 25,000 | 223.5244 USD |
Sale | 28,458 | 225.7000 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 9 Feb 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
|
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210209005714/en/
Copyright Business Wire 2021